Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

$18M Seized From Massachusetts Compounding Pharmacy Accounts

By Drug Discovery Trends Editor | January 7, 2015

pharma compounding spendingAuthorities have seized over $18 million from the owners of a Massachusetts compounding pharmacy at the center of a 2012 meningitis outbreak that killed 64 people nationwide.
U.S. Attorney Carmen Ortiz said the funds were seized from 13 different financial institutions as a result of seizure warrants unsealed Tuesday.
About $16.8 million was frozen in accounts connected to husband-and-wife Douglas and Carla Conigliaro of Dedham. Carla Conigliaro was a majority shareholder at the now-shuttered New England Compounding Center in Framingham.
The Conigliaros have been charged with transferring assets following the outbreak, which was traced to tainted steroid injections made by the company.
According to Ortiz’s office, the Conigliaros transferred millions of dollars the same month that their company surrendered its pharmacy license and shortly before the company petitioned for bankruptcy. They also allegedly transferred millions more after a bankruptcy court issued two orders prohibiting them from transferring any assets.
Authorities say they seized another $1.5 million from accounts held by Barry Cadden, the company’s co-founder and a shareholder.
Cadden faces 25 counts of second-degree murder and is among 14 former employees charged in a federal racketeering conspiracy that authorities say is the largest U.S. criminal case ever brought over contaminated medicine.
New England Compounding Center employees are accused of using expired ingredients and failing to follow cleanliness standards, resulting in tainted steroid injections. More than 750 people in 20 states fell ill and 64 died. All 14 defendants have pleaded not guilty to the charges.

Filed Under: Drug Discovery

 

Related Articles Read More >

Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE